The administration of transforming growth factor beta superfamily ligands, including GDF15 and MIC-1, has been shown to reduce body weight and food intake in mouse and human models, respectively, making them advantageous in the treatment of obesity
Liraglutide (Victoza) As one of the earlier once daily GLP-1 options, Victoza received FDA approval on January 25, 2010 for type 2 diabetes management
Balances melanin production: Glutathione interferes with the production of melanin by darkening spots, lightening scars, and giving skin more of a smooth complexion
Key Facts Lilly announced the results of two phase 3 trials on Thursday, saying it will file for FDA approval of the drugpotentially adding another GLP-1 to its lineupin the first quarter of 2027
[PubMed] [Google Scholar] Radkar P